myeloma protein MOPC 173

11/01/1972 - "Studies on mouse plasmocytoma cells MOPC 173 grown "in vitro". "
02/01/1983 - "A tRNA(adenine-1)methyltransferase and a tRNA(cytosine-5)methyltransferase have been partially purified from mouse plasmocytoma MOPC 173. "
11/26/1979 - "These membranes are purified from the MF2S cell line issued from the murine plasmacytoma MOPC 173. "
08/05/1975 - "The K+ content and the K+ flux were measured in the cell lines ME2 and MF2 isolated from plasmocytoma MOPC 173. "
11/06/1972 - "[Obtaining a cell line from MOPC 173 murine plasmacytoma cultivated in a medium without serum]."

01/01/1976 - "A L chain-producing variant arising spontaneously from the MOPC 173 tumor also failed to secrete any L chains. "
01/01/1976 - "Tryptic peptide mapping of the H and L chains produced by the MOPC 173 tumor and the variant spleen clone failed to demonstrate any differences in the H chains, but there were definite chemical differences in the L chains. "
01/01/1976 - "MOPC 173 tumor cells were cloned in the spleens of normal BALB/c mice and 1 of 23 spleen clones appeared to differ from the parent tumor in demonstrating a) a transient block in the assembly of H2L2 at the H2 level, leading to delayed formation and secretion of H2L2, b) appreciable amounts of non-covalently bonded H2L, c) an abnormal intracellular immunoglobulin species, H4, d) production of equimolar amounts of H and L chains. "
01/01/1976 - "The IgG2a producing MOPC 173 tumor synthesizes heavy (H) and light (L) chains and assembles them into H2L2 utilizing heavy chain dimers (H2) and H2L as the major precursors. "
01/01/1976 - "Immunoglobulin biosynthesis by the MOPC 173 mouse myeloma tumor and a variant spleen clone."

06/09/1981 - "Fluorescent Fab fragments of the inhibiting antibodies bound to MF2s and MOPC 173 plasmacytoma cells, whereas no fluorescence was observed with P 1798 thymoma cells in which the enzyme was absent. "

01/01/1985 - "The effect of two muramyl dipeptides, N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) and N-acetylmuramyl-D-alanyl-D-isoglutamine (MDP(D-D)), on the in vitro growth of two murine ascitic plasmacytomas, MOPC 173 and TEPC 15, and on an ascitic lymphoma cell line, ABPL2, was studied. "